Liquidia Corp (LQDA): who owns it and who trades it
As of Nov 16, 2026, LQDA insiders reported 171 open-market sales worth $228M and 1 purchase worth $318K in the last 12 months, with 34% of the sale value made under pre-set 10b5-1 plans. The largest seller was Stephen M Bloch (Director), with $125M. 2 of the 50 famous funds we follow held it at their last quarter end.
Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.
At a glance
Who is buying and selling Liquidia
From the latest filingsOverall: about as much buying as selling. Insiders mostly sold. Funds and famous investors mostly bought.
Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.
Who owns LQDA
335 funds and institutions reported LQDA shares worth $5.8B at the end of Q2 2026, about 82% of the company. The largest holder is BlackRock, Inc. with 12.1%.
Funds and institutions (13F) 82%Everyone else 18%
10 largest owners, by share of the company
Top 20 owners
| Owner | Shares | % of company | Value | Change since Q1 2026 |
|---|---|---|---|---|
| BlackRock, Inc. | 10.79M | 12.13% | $860M | +97% |
| Farallon Capital Management, L.l.c. | 8.37M | 9.41% | $667M | -3% |
| Caligan Partners LP | 8.12M | 9.13% | $647M | No change |
| Findell Capital Management LLC | 3.50M | 3.94% | $279M | No change |
| Vanguard Capital Management LLC | 3.14M | 3.53% | $250M | +7% |
| State Street Corp | 3.03M | 3.41% | $242M | +61% |
| Opaleye Management Inc. | 2.45M | 2.75% | $195M | -4% |
| Geode Capital Management, LLC | 2.12M | 2.39% | $169M | +10% |
| Bank of America Corp | 1.99M | 2.24% | $159M | -13% |
| T. Rowe Price Associates | 1.94M | 2.18% | $155M | +104% |
| Vanguard Portfolio Management LLC | 1.53M | 1.72% | $122M | +142% |
| Caprock Group, LLC | 1.41M | 1.59% | $112M | +3% |
| Mpm Bioimpact LLC | 1.39M | 1.56% | $111M | -1% |
| D. E. Shaw & Co., Inc. | 1.27M | 1.43% | $101M | +45% |
| Fuller & Thaler Asset Management, Inc. | 1.21M | 1.36% | $96.4M | – |
| Goldman Sachs Group Inc | 958,892 | 1.08% | $76.5M | +18% |
| Federated Hermes, Inc. | 816,187 | 0.92% | $65.1M | +86% |
| Northern Trust Corp | 709,063 | 0.80% | $56.5M | +22% |
| Charles Schwab Investment Management Inc | 674,033 | 0.76% | $53.7M | +21% |
| Sixth Street Partners Management Company, L.P. | 674,033 | 0.76% | $53.7M | – |
From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.
Insider trades
In the last 12 months, LQDA insiders reported $318K of open-market purchases and $228M of sales. 34% of the sale value was under a 10b5-1 plan, a schedule set up in advance.
Purchases and sales by month
Latest trades
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Jason Adair | Chief Business Officer | Sale plan | 688 | $43.19 | $29.7K | Form 4 |
| Oct 26, 2026 | Dana Boyle | Chief Accounting Officer | Sale plan | 1,581 | $43.19 | $68.3K | Form 4 |
| Oct 12, 2026 | Jason Adair | Chief Business Officer | Sale plan | 7,301 | $28.48 | $208K | Form 4 |
| Oct 12, 2026 | Dana Boyle | Chief Accounting Officer | Sale plan | 5,892 | $28.48 | $168K | Form 4 |
| Oct 12, 2026 | Roger Jeffs | CEO | Sale plan | 32,744 | $28.48 | $933K | Form 4 |
| Oct 12, 2026 | Michael Kaseta | CFO | Sale plan | 18,938 | $28.48 | $539K | Form 4 |
| Oct 12, 2026 | Sanjeev Khindri | Chief Development Office | Sale plan | 1,101 | $28.48 | $31.4K | Form 4 |
| Oct 12, 2026 | Sarah Krepp | Chief Human Resource Off | Sale plan | 5,245 | $28.48 | $149K | Form 4 |
| Oct 12, 2026 | Scott Moomaw | Chief Commercial Officer | Sale plan | 8,863 | $28.48 | $252K | Form 4 |
| Oct 12, 2026 | Rajeev Saggar | Chief Medical Officer | Sale plan | 9,218 | $28.48 | $263K | Form 4 |
| Oct 12, 2026 | Russell Schundler | General Counsel | Sale plan | 13,692 | $28.48 | $390K | Form 4 |
| Oct 5, 2026 | Stephen M Bloch | Director | Sale | 235,477 | $27.13 | $6.4M | Form 4 |
| Sep 14, 2026 | Raman Singh | Director | Sale | 8,468 | $66.16 | $560K | Form 4 |
| Sep 11, 2026 | Raman Singh | Director | Sale | 9,024 | $68.62 | $619K | Form 4 |
| Sep 1, 2026 | Sarah Krepp | Chief Human Resource Off | Sale plan | 274 | $67.76 | $18.6K | Form 4 |
| Aug 21, 2026 | Jason Adair | Chief Business Officer | Sale plan | 41,832 | $69.09 | $2.9M | Form 4 |
| Aug 21, 2026 | Jason Adair | Chief Business Officer | Sale plan | 31,799 | $69.09 | $2.2M | Form 4 |
| Aug 20, 2026 | Katherine Rielly-Gauvin | Director | Sale plan | 18,393 | $72.23 | $1.3M | Form 4 |
| Aug 19, 2026 | Katherine Rielly-Gauvin | Director | Sale plan | 36,789 | $74.99 | $2.8M | Form 4 |
| Aug 19, 2026 | Rajeev Saggar | Chief Medical Officer | Sale | 50,000 | $74.06 | $3.7M | Form 4 |
| Aug 17, 2026 | Rajeev Saggar | Chief Medical Officer | Sale | 29,534 | $76.84 | $2.3M | Form 4 |
| Jul 27, 2026 | Dana Boyle | Chief Accounting Officer | Sale plan | 1,600 | $87.53 | $140K | Form 4 |
| Jul 27, 2026 | Jason Adair | Chief Business Officer | Sale plan | 688 | $87.53 | $60.2K | Form 4 |
| Jul 23, 2026 | Stephen M Bloch | Director | Sale | 3,600 | $90.71 | $327K | Form 4 |
| Jul 23, 2026 | Stephen M Bloch | Director | Sale | 96,400 | $89.44 | $8.6M | Form 4 |
| Jul 22, 2026 | Stephen M Bloch | Director | Sale | 37,406 | $87.70 | $3.3M | Form 4 |
| Jul 22, 2026 | Stephen M Bloch | Director | Sale | 48,032 | $88.65 | $4.3M | Form 4 |
| Jul 22, 2026 | Stephen M Bloch | Director | Sale | 14,562 | $89.24 | $1.3M | Form 4 |
| Jul 21, 2026 | Stephen M Bloch | Director | Sale | 556 | $80.66 | $44.8K | Form 4 |
| Jul 21, 2026 | Stephen M Bloch | Director | Sale | 74,444 | $79.98 | $6M | Form 4 |
| Jul 20, 2026 | Stephen M Bloch | Director | Sale | 3,596 | $79.55 | $286K | Form 4 |
| Jul 13, 2026 | Sarah Krepp | Chief Human Resource Off | Sale plan | 558 | $71.39 | $39.8K | Form 4 |
| Jul 13, 2026 | Sarah Krepp | Chief Human Resource Off | Sale plan | 7,306 | $71.52 | $523K | Form 4 |
| Jul 13, 2026 | Sanjeev Khindri | Chief Development Office | Sale plan | 84 | $71.39 | $6K | Form 4 |
| Jul 13, 2026 | Sanjeev Khindri | Chief Development Office | Sale plan | 1,101 | $71.52 | $78.7K | Form 4 |
| Jul 13, 2026 | Michael Kaseta | CFO | Sale plan | 1,453 | $71.39 | $104K | Form 4 |
| Jul 13, 2026 | Michael Kaseta | CFO | Sale plan | 18,977 | $71.52 | $1.4M | Form 4 |
| Jul 13, 2026 | Roger Jeffs | CEO | Sale plan | 32,744 | $71.52 | $2.3M | Form 4 |
| Jul 13, 2026 | Roger Jeffs | CEO | Sale plan | 2,505 | $71.39 | $179K | Form 4 |
| Jul 13, 2026 | Jason Adair | Chief Business Officer | Sale plan | 562 | $71.39 | $40.1K | Form 4 |
| Jul 13, 2026 | Jason Adair | Chief Business Officer | Sale plan | 7,301 | $71.52 | $522K | Form 4 |
| Jul 13, 2026 | Russell Schundler | General Counsel | Sale plan | 13,692 | $71.52 | $979K | Form 4 |
| Jul 13, 2026 | Russell Schundler | General Counsel | Sale plan | 1,046 | $71.39 | $74.7K | Form 4 |
| Jul 13, 2026 | Rajeev Saggar | Chief Medical Officer | Sale plan | 9,223 | $71.52 | $660K | Form 4 |
| Jul 13, 2026 | Rajeev Saggar | Chief Medical Officer | Sale plan | 703 | $71.39 | $50.2K | Form 4 |
| Jul 13, 2026 | Scott Moomaw | Chief Commercial Officer | Sale plan | 675 | $71.39 | $48.2K | Form 4 |
| Jul 13, 2026 | Scott Moomaw | Chief Commercial Officer | Sale plan | 8,864 | $71.52 | $634K | Form 4 |
| Jul 13, 2026 | Dana Boyle | Chief Accounting Officer | Sale plan | 8,361 | $71.52 | $598K | Form 4 |
| Jul 13, 2026 | Dana Boyle | Chief Accounting Officer | Sale plan | 641 | $71.39 | $45.8K | Form 4 |
| Jul 7, 2026 | Stephen M Bloch | Director | Sale | 27,282 | $81.31 | $2.2M | Form 4 |
| Jul 7, 2026 | Stephen M Bloch | Director | Sale | 22,718 | $80.48 | $1.8M | Form 4 |
| Jul 6, 2026 | Stephen M Bloch | Director | Sale | 25,000 | $80.18 | $2M | Form 4 |
| Jul 1, 2026 | Stephen M Bloch | Director | Sale | 24,147 | $79.45 | $1.9M | Form 4 |
| Jul 1, 2026 | Stephen M Bloch | Director | Sale | 853 | $80.05 | $68.3K | Form 4 |
| Jun 22, 2026 | Stephen M Bloch | Director | Sale | 69,500 | $75.54 | $5.3M | Form 4 |
| Jun 22, 2026 | Stephen M Bloch | Director | Sale | 30,500 | $76.18 | $2.3M | Form 4 |
| Jun 15, 2026 | Stephen M Bloch | Director | Sale | 82,740 | $71.42 | $5.9M | Form 4 |
| Jun 15, 2026 | Stephen M Bloch | Director | Sale | 2,322 | $72.08 | $167K | Form 4 |
| Jun 12, 2026 | Stephen M Bloch | Director | Sale | 13,095 | $72.15 | $945K | Form 4 |
| Jun 12, 2026 | Stephen M Bloch | Director | Sale | 97,954 | $71.37 | $7M | Form 4 |
| Jun 11, 2026 | Sarah Krepp | Chief Human Resource Off | Sale plan | 19,131 | $70.28 | $1.3M | Form 4 |
| Jun 11, 2026 | Sarah Krepp | Chief Human Resource Off | Sale plan | 5,749 | $70.28 | $404K | Form 4 |
| Jun 11, 2026 | Stephen M Bloch | Director | Sale | 686 | $72.41 | $49.7K | Form 4 |
| Jun 11, 2026 | Stephen M Bloch | Director | Sale | 92,128 | $71.74 | $6.6M | Form 4 |
| Jun 11, 2026 | Stephen M Bloch | Director | Sale | 20,208 | $71.07 | $1.4M | Form 4 |
| Jun 11, 2026 | Stephen M Bloch | Director | Sale | 85,285 | $69.87 | $6M | Form 4 |
| Jun 11, 2026 | Stephen M Bloch | Director | Sale | 25,117 | $68.91 | $1.7M | Form 4 |
| Jun 11, 2026 | Stephen M Bloch | Director | Sale | 17,369 | $67.90 | $1.2M | Form 4 |
| Jun 11, 2026 | Stephen M Bloch | Director | Sale | 1,476 | $66.40 | $98K | Form 4 |
| Jun 10, 2026 | Stephen M Bloch | Director | Sale | 14,416 | $64.48 | $930K | Form 4 |
| Jun 10, 2026 | Stephen M Bloch | Director | Sale | 103,301 | $65.54 | $6.8M | Form 4 |
| Jun 10, 2026 | Stephen M Bloch | Director | Sale | 28,237 | $66.30 | $1.9M | Form 4 |
| Jun 9, 2026 | Stephen M Bloch | Director | Sale | 8,034 | $65.24 | $524K | Form 4 |
| Jun 9, 2026 | Stephen M Bloch | Director | Sale | 64,500 | $64.27 | $4.1M | Form 4 |
| Jun 8, 2026 | Sanjeev Khindri | Chief Development Office | Sale plan | 4,134 | $65.46 | $271K | Form 4 |
| Jun 8, 2026 | Stephen M Bloch | Director | Sale | 2,804 | $66.19 | $186K | Form 4 |
| Jun 8, 2026 | Stephen M Bloch | Director | Sale | 106,310 | $64.49 | $6.9M | Form 4 |
| Jun 8, 2026 | Stephen M Bloch | Director | Sale | 39,187 | $65.38 | $2.6M | Form 4 |
| Jun 5, 2026 | Stephen M Bloch | Director | Sale | 2,064 | $64.14 | $132K | Form 4 |
| Jun 4, 2026 | Paul B Manning | Director | Sale | 19,125 | $62.62 | $1.2M | Form 4 |
| Jun 4, 2026 | Paul B Manning | Director | Sale | 68,265 | $63.83 | $4.4M | Form 4 |
| Jun 4, 2026 | Paul B Manning | Director | Sale | 88,487 | $64.28 | $5.7M | Form 4 |
| Jun 4, 2026 | Paul B Manning | Director | Sale | 11,513 | $63.13 | $727K | Form 4 |
| Jun 4, 2026 | Paul B Manning | Director | Sale | 12,610 | $64.42 | $812K | Form 4 |
| Jun 4, 2026 | Stephen M Bloch | Director | Sale | 1,420 | $66.08 | $93.8K | Form 4 |
| Jun 4, 2026 | Stephen M Bloch | Director | Sale | 35,208 | $65.58 | $2.3M | Form 4 |
| Jun 4, 2026 | Stephen M Bloch | Director | Sale | 46,108 | $64.47 | $3M | Form 4 |
| Jun 3, 2026 | Arthur S Kirsch | Director | Sale | 10,000 | $54.80 | $548K | Form 4 |
| Jun 2, 2026 | Arthur S Kirsch | Director | Sale | 5,000 | $56.00 | $280K | Form 4 |
| Jun 1, 2026 | Sarah Krepp | Chief Human Resource Off | Sale plan | 276 | $60.87 | $16.8K | Form 4 |
| Jun 1, 2026 | Arthur S Kirsch | Director | Sale | 15,000 | $60.22 | $903K | Form 4 |
| May 27, 2026 | Roger Jeffs | CEO | Sale plan | 6,428 | $62.18 | $400K | Form 4 |
| May 26, 2026 | Roger Jeffs | CEO | Sale plan | 25,000 | $60.38 | $1.5M | Form 4 |
| May 22, 2026 | Roger Jeffs | CEO | Sale plan | 25,000 | $61.52 | $1.5M | Form 4 |
| May 21, 2026 | Raman Singh | Director | Sale | 29,494 | $60.13 | $1.8M | Form 4 |
| May 21, 2026 | Roger Jeffs | CEO | Sale plan | 25,000 | $61.13 | $1.5M | Form 4 |
| May 20, 2026 | Roger Jeffs | CEO | Sale plan | 25,000 | $61.30 | $1.5M | Form 4 |
| May 19, 2026 | David Edward Johnson +1 | Director | Sale | 5,300 | $59.98 | $318K | Form 4 |
| May 19, 2026 | David Edward Johnson +1 | Director | Purchase | 5,300 | $59.98 | $318K | Form 4 |
| May 19, 2026 | Roger Jeffs | CEO | Sale plan | 25,000 | $58.65 | $1.5M | Form 4 |
Latest 100 of 172 trades in the last 12 months.
Insiders by value traded
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| Stephen M Bloch | Director | – | $125M | Oct 5, 2026 |
| Roger Jeffs | Chief Executive Officer, Director | – | $32.2M | Oct 12, 2026 |
| Michael Kaseta | CFO and COO | – | $16.2M | Oct 12, 2026 |
| Paul B Manning | Director | – | $12.8M | Jun 4, 2026 |
| Rajeev Saggar | Chief Medical Officer | – | $9.4M | Oct 12, 2026 |
| Jason Adair | Chief Business Officer | – | $7.9M | Oct 26, 2026 |
| Scott Moomaw | Chief Commercial Officer | – | $5.7M | Oct 12, 2026 |
| Katherine Rielly-Gauvin | Director | – | $4.1M | Aug 20, 2026 |
| Sarah Krepp | Chief Human Resource Officer | – | $3.8M | Oct 12, 2026 |
| Raman Singh | Director | – | $3.7M | Sep 14, 2026 |
| Russell Schundler | General Counsel | – | $3.1M | Oct 12, 2026 |
| Dana Boyle | Chief Accounting Officer | – | $1.8M | Oct 26, 2026 |
| Arthur S Kirsch | Director | – | $1.7M | Jun 3, 2026 |
| David Edward Johnson | Director, 10% owner | $318K | $318K | May 19, 2026 |
| Sanjeev Khindri | Chief Development Officer | – | $387K | Oct 12, 2026 |
What this data shows, and what it doesn't
- Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
- Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
- "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
- Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
- Filings are self-reported and can be amended. Each trade links to its original filing. Methodology
LQDA short interest
High short interest. 19.4% of LQDA shares are sold short: about 1 share in 5. Over the last 12 reports the number of shares short went up 72%.
As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.
As of Oct 30, 2026, 17.51M LQDA shares were sold short, 19.4% of the shares outstanding, up 1.2% from the report before. At the average daily volume of 3.31M shares, buying them all back would take about 5.3 trading days (days to cover).
Shares short, % of all shares
Days to cover
Every report
| Settlement date | Shares short | % of shares | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|---|
| Oct 30, 2026 | 17.51M | 19.43% | +1% | 3.31M | 5.3 |
| Oct 15, 2026 | 17.30M | 19.33% | +37% | 8.74M | 2.0 |
| Sep 30, 2026 | 12.64M | 14.12% | +2% | 3.29M | 3.8 |
| Sep 15, 2026 | 12.38M | 13.83% | +4% | 1.08M | 11.4 |
| Aug 31, 2026 | 11.86M | 13.25% | No change | 1.17M | 10.2 |
| Aug 14, 2026 | 11.86M | 13.25% | -1% | 1.84M | 6.5 |
| Jul 31, 2026 | 11.96M | 13.37% | -3% | 1.45M | 8.2 |
| Jul 15, 2026 | 12.33M | 13.87% | -6% | 1.34M | 9.2 |
| Jun 30, 2026 | 13.18M | 14.82% | +14% | 3.25M | 4.0 |
| Jun 15, 2026 | 11.61M | 13.06% | +17% | 2.28M | 5.1 |
| May 29, 2026 | 9.96M | 11.20% | -2% | 1.28M | 7.8 |
| May 15, 2026 | 10.21M | 11.48% | +3% | 2.07M | 4.9 |
Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks
Liquidia company events
Liquidia filed 10 reports on Form 8-K in the last 12 months, all of them routine, such as results and vote reports. The latest was on Nov 10, 2026.
- Nov 10, 2026AnnouncementThe Company updated its corporate presentation that it uses for presentations at healthcare conferences and to analysts, current stockholders, and others. Filing
- Oct 14, 2026AgreementLiquidia Technologies, Inc., a Delaware corporation, a wholly-owned subsidiary of Liquidia Corporation, and United Therapeutics Corporation entered into a settlement agreement regarding all ongoing litigation between the Company and UTC, including, among other matters, the resolution of pending… Filing
- Sep 30, 2026AnnouncementLiquidia Corporation, a Delaware corporation, issued a press release regarding the litigation filed by United Therapeutics Corporation in the U.S. District Court for the District of Delaware under the Hatch-Waxman Act concerning U.S. Patent No. 11,826,327 and the Company’s lead product, YUTREPIA ®… Filing
- Sep 3, 2026AnnouncementLiquidia Corporation, a Delaware corporation, issued a press release announcing that the U.S. Food and Drug Administration has granted Fast Track Designation to YUTREPIA ® (treprostinil) inhalation powder for the treatment of Raynaud’s phenomenon associated with systemic sclerosis. Filing
- Aug 12, 2026AnnouncementThe Company updated its corporate presentation that it uses for presentations at healthcare conferences and to analysts, current stockholders, and others. Filing
- Jun 17, 2026VoteReported shareholder vote results. Filing
- Jun 8, 2026AnnouncementLiquidia Corporation, a Delaware corporation, issued a press release announcing that it will be added to the S&P SmallCap 600® Index, effective prior to the opening of trading on June 22, 2026. Filing
- May 11, 2026AnnouncementThe Company updated its corporate presentation that it uses for presentations at healthcare conferences and to analysts, current stockholders, and others. Filing
- Mar 5, 2026ResultsReleased financial results. Filing
- Jan 9, 2026AnnouncementShared information with investors. Filing
From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week
Liquidia financials
Famous investors that hold LQDA
2 of the 50 well-known investors we track reported holding LQDA in their latest 13F filing. The largest position is Jim Simons's, worth $7.3M.
| Fund | Quarter | Shares | Value | Of portfolio | Change |
|---|---|---|---|---|---|
| Jim Simons · Renaissance Technologies | Q3 2026 | 242,653 | $7.3M | 0.0% | +4% |
| Ken Griffin · Citadel Advisors | Q3 2026 | 240,230 | $7.3M | 0.0% | New |
From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.
Questions about Liquidia Corp (LQDA) stock
Who owns the most LQDA stock?
The largest reported owner of Liquidia Corp (LQDA) is BlackRock, Inc., with 12.1% of the company. In total, 335 funds and institutions reported holding LQDA at the end of Q2 2026, together about 82% of the shares. See the largest owners.
Are LQDA insiders buying or selling?
In the last 12 months, LQDA insiders reported 1 open-market purchase worth $318K and 171 sales worth $228M. The latest trade was on Oct 26, 2026. See every trade.
What is the short interest in LQDA?
As of Oct 30, 2026, 17.51M LQDA shares were sold short, 19.4% of the shares outstanding, up 1.2% from the report before. At the average daily volume of 3.31M shares, buying them all back would take about 5.3 trading days (days to cover). See the history.
Which famous investors hold LQDA?
2 of the 50 well-known investors we track reported LQDA in their latest 13F filing, including Jim Simons, Ken Griffin. The largest position is worth $7.3M. See all holders.
Executive pay
Liquidia's chief executive was paid a total of $7.7M for the year ended Dec 31, 2025, up 14% from $6.8M the year before. In the last 12 months, Liquidia's executives and directors bought $318K of stock on the open market and sold $228M.
From the pay versus performance table in the company's annual proxy statement (DEF 14A), as the company reported it. If the chief executive changed during the year, the company reports each person separately and this shows one of them.
Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.